HOUSTON, June 29, 2016 /PRNewswire/ -- Minerco, Inc. (OTC: MINE) announces an opening, initial purchase order for 2,500 units of CB Squeeze, by the The Herbal Collection™. This opening order represents approximately half of the upcoming pilot production run of 5,000 – 8,000 units, depending on process size. The initial placement and purchase order from The HempLife Group, a Midwest based distributor and retailer specializing in cutting edge hemp based and all natural products, is expected to be available in retailers including Green Remedy, New Earth Hemp Solutions, Carolina Hemp Company and Hemp Dog Café.
CB Squeeze, packaged in a 1 oz. squeeze pack and enhanced with micellized (encapsulated for slow release) Cannabidiol (CBD) and natural herbal extracts, is scheduled for its pilot production run in the coming weeks. The higher than expected demand for CB Squeeze, even before online availability, is expected to require another production run as soon as the pilot production run is completed and passes quality control standards.
"CB Squeeze was designed for predominantly online sales, so this opening PO from a brick and mortar distributor is a tactical advantage that we plan to exploit further. The HempLife Group and their retail partners have also requested delivery of CB Shot and CB Tea as soon as possible. With this opening order, expected follow on orders and a $5.99 target retail price, we expect to ramp up very rapidly after this pilot run," said V. Scott Vanis, Minerco's Chairman and CEO. "The bio-availability studies are also forth coming on The Herbal Collection's micellization technology, and preliminary results are a higher bio availability than previously quoted."
About Minerco, Inc.
Minerco, Inc. (OTC:MINE) is an emerging growth company specializing in the food and beverage industry. Its portfolio includes Athena Brands, Inc., The Herbal Collection™ and Coffee Boost™. Athena Brands, Inc. is a specialty beverage company that develops, produces, markets and distributes a diversified collection of forward-thinking, enhanced and better-for-you consumer brands. The Athena Brands portfolio includes Avanzar Sales & Distribution, LLC, VitaminFIZZ®, Vitamin Creamer® and Island Style™.
About CB Squeeze
CB Squeeze contains the highest quality natural herbs combined with a propriety blend of micellized CBD in a squeeze pack ideal for the on-the-go consumer. CB Squeeze has 5 milligrams of micellized high grade CBD (the equivalent of over 25 milligrams of non-micellized CBD) sourced from CBD dominant hemp plants from an established "grass roots" supplier.
The proven micellization technology ensures the highest bio availability and absorption rates of the CBD to the consumer. This state of the art micellization technology combined with the widely accepted health benefits of CBD sourced from hemp, and the ability to sell CB Squeeze in all 50 states and online, is expected to strategically position Minerco's CB Squeeze within the category.
Cannabidiol (CBD) is a compound in hemp that has shown to offer beneficial medical effects to the body without the psychoactive effects associated with Tetrahydrocannabinol (THC). Scientific and clinical research, much of it sponsored by the US government, underscores CBD's potential as a treatment for a wide range of conditions, including arthritis, diabetes, alcoholism, MS, chronic pain, schizophrenia, PTSD, depression, antibiotic-resistant infections, epilepsy, paranoia and other neurological disorders. CBD has demonstrable neuroprotective and neurogenic effects, and its anti-cancer properties are currently being investigated at several academic research centers in the United States and elsewhere.
Micelles are the atom sized stable aggregates of surfactant molecules, which form spontaneously in surfactant solutions. Put simply: Micellization is the scientific process of coating a particle in a surfactant solution to yield a higher potency at delivery.
Details of the Company's business, finances and agreements can be found as part of the Company's continuous public disclosure as a fully reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission's ("SEC") EDGAR database. For more information, please visit: www.minerco.com. The above statements have not been evaluated by the Food and Drug Administration (FDA). These products are not intended to diagnose, treat, cure or prevent any disease.
Safe Harbor Statement
This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934 that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although we believe that the expectations and assumptions upon which they are based are reasonable, we can give no assurance that such expectations and assumptions will prove to have been correct. Some of these uncertainties include, without limitation, the company's ability to perform under existing contracts or to procure future contracts. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous factors and uncertainties, including without limitation, successful implementation of our business strategy and competition, any of which may cause actual results to differ materially from those described in the statements. We undertake no obligation and do not intend to update, revise or otherwise publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of any unanticipated events. Although we believe that our expectations are based on reasonable assumptions, we can give no assurance that our expectations will materialize. Many factors could cause actual results to differ materially from our forward-looking statements.
V. Scott Vanis
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/minerco-secures-initial-placement-for-cb-squeeze-300292115.html
SOURCE Minerco, Inc.